The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described

Clinical Endocrinology

Volumn 82, Issue 1, 2015, Pages 142-146

  Delhanty, Patric J D ^a   Huisman, Martin ^a   Julien, Michel ^b   Mouchain, Karine ^c   Brune, Patrick ^c   Themmen, Axel P N ^a   Abribat, Thierry ^b   Van Der Lely, Aart J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Alizé Pharma   (France)

^c BERTIN TECHNOLOGIES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULPHONYL FLUORIDE; ESTERASE INHIBITOR; GHRELIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; ESTERASE;

ACYLATION; ADULT; ARTICLE; BLOOD SAMPLING; DEACYLATION; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; STORAGE TEMPERATURE; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD EXAMINATION; STANDARDS;

ACYLATION; ADULT; ENZYME INHIBITORS; ESTERASES; FEMALE; GHRELIN; HEMATOLOGIC TESTS; HUMANS; MALE;

EID: 84927673595     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12489     Document Type: Article

References (22)

1. van der Lely, A.J., Tschöp, M., Heiman, M.L. et al. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews, 25, 426-457.
2. Kojima, M., Hosoda, H., Date, Y. et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
3. Delhanty, P.J. & van der Lely, A.J. (2011) Ghrelin and glucose homeostasis. Peptides, 32, 2309-2318.
4. Cummings, D.E. & Overduin, J. (2007) Gastrointestinal regulation of food intake. Journal of Clinical Investigation, 117, 13-23.
5. Delhanty, P.J., Neggers, S.J. & van der Lely, A.J. (2013) Des-acyl ghrelin: a metabolically active Peptide. Endocrine Development, 25, 112-121.
6. Ozcan, B., Neggers, S.J., Miller, A.R. et al. (2013) Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? European Journal of Endocrinology, 170, 799-807.
7. Hosoda, H., Kojima, M., Matsuo, H. et al. (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochemical and Biophysical Research Communications, 279, 909-913.
8. Broglio, F., Gottero, C., Prodam, F. et al. (2004) Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism, 89, 3062-3065.
9. Liu, J., Prudom, C.E., Nass, R. et al. (2008) Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. Journal of Clinical Endocrinology and Metabolism, 93, 1980-1987.
10. Prudom, C., Liu, J., Patrie, J. et al. (2010) Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. Journal of Clinical Endocrinology and Metabolism, 95, 2351-2358.
11. De Vriese, C., Gregoire, F., Lema-Kisoka, R. et al. (2004) Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology, 145, 4997-5005.
12. Gutierrez, J.A., Willency, J.A., Knierman, M.D. et al. (2012) From ghrelin to ghrelin's O-acyl transferase. Methods in Enzymology, 514, 129-146.
13. Tong, J., Dave, N., Mugundu, G. et al. (2013) The Pharmacokinetics of Acyl, Desacyl and Total Ghrelin in Healthy Human Subjects. European Journal of Endocrinology/European Federation of Endocrine Societies, 168, 821-828.
14. Blatnik, M. & Soderstrom, C.I. (2011) A practical guide for the stabilization of acylghrelin in human blood collections. Clinical Endocrinology, 74, 325-331.
15. Benso, A., St-Pierre, D., Prodam, F. et al. (2012) Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. European Journal of Endocrinology/European Federation of Endocrine Societies, 166, 911-916.
16. Broglio, F., Prodam, F., Riganti, F. et al. (2007) Unacylated ghrelin (UAG) Enhances the Early Insulin Response to Meal, Improves Glucose Metabolism and Decrease Free Fatty Acids Levels in Healthy Volunteers. Presented at the Annual Meeting of the Endocrine Society, Toronto. Endocrine Abstracts 14, p79.
17. Gauna, C., Meyler, F.M., Janssen, J.A. et al. (2004) Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism, 89, 5035-5042.
18. Blatnik, M., Soderstrom, C.I., Dysinger, M. et al. (2012) Prandial ghrelin attenuation provides evidence that des-acyl ghrelin may be an artifact of sample handling in human plasma. Bioanalysis, 4, 2447-2455.
19. Trivedi, A., Babic, S. & Chanoine, J.P. (2011) Pitfalls in the determination of human acylated ghrelin plasma concentrations using a double antibody enzyme immunometric assay. Clinical Biochemistry, 45, 178-180.
20. Nass, R., Farhy, L.S., Liu, J. et al. (2013) Age-dependent decline in acyl-ghrelin concentrations and reduced association of acylghrelin and growth hormone in healthy older adults. Journal of Clinical Endocrinology and Metabolism, 99, 602-608.
21. Barazzoni, R., Zanetti, M., Ferreira, C. et al. (2007) Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 92, 3935-3940.
22. St-Pierre, D.H., Karelis, A.D., Coderre, L. et al. (2007) Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 92, 264-269.